Citigroup’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1
| Closed | -$1K | – | 4961 |
|
|
2022
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 5169 |
|
|
2022
Q1 | $2K | Sell |
1
-5
| -83% | -$10K | ﹤0.01% | 5211 |
|
|
2021
Q4 | $30K | Buy |
6
+4
| +200% | +$20K | ﹤0.01% | 4495 |
|
|
2021
Q3 | $13K | Buy |
2
+1
| +100% | +$6.5K | ﹤0.01% | 4638 |
|
|
2021
Q2 | $8K | Hold |
1
| – | – | ﹤0.01% | 5051 |
|
|
2021
Q1 | $9K | Sell |
1
-1
| -50% | -$9K | ﹤0.01% | 5010 |
|
|
2020
Q4 | $17K | Buy |
2
+1
| +100% | +$8.5K | ﹤0.01% | 4699 |
|
|
2020
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 4728 |
|
|
2020
Q2 | $10K | Sell |
1
-1
| -50% | -$10K | ﹤0.01% | 4623 |
|
|
2020
Q1 | $15K | Hold |
2
| – | – | ﹤0.01% | 4478 |
|
|
2019
Q4 | $24K | Buy |
+2
| New | +$24K | ﹤0.01% | 4402 |
|
|
2019
Q3 | – | Sell |
-2
| Closed | -$33K | – | 4829 |
|
|
2019
Q2 | $33K | Sell |
2
-4
| -67% | -$66K | ﹤0.01% | 4341 |
|
|
2019
Q1 | $107K | Buy |
+6
| New | +$107K | ﹤0.01% | 3529 |
|